FDA Investigator Robert W Fisher
Robert W Fisher has conducted inspections on 3 sites in 2 countries as of 08 Jun 2023. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
3
Last Inspection Date:
08 Jun 2023
Investigator Role:
FDA Investigation Participant
Redica ID:
Countries of Inspections:
Mexico,
Canada
FDA Investigators that have inspected at least one site in common with Robert W Fisher:
Anita R Michael,
Burnell M Henry,
CDR Donald Ertel,
Cynthia Jim, CSO,
Douglas F Frazier,
Dr. Gang Wang, PhD,
Helen R Bester,
Jacqueline Mdiaz Albertini,
Jonathan G Matrisciano,
Julie D Bringger,
LCDR Debra Emerson,
Linda Thai,
Lori A Holmquist,
Lori Peters,
Mariza M Jafary,
Michael C Kennedy, PhD,
Michael R Goga,
Mihaly S Ligmond,
Nancy T Waites,
Omotunde O Osunsanmi,
Paula A Trost,
Prabhu P Raju,
Rose Ashley,
Simone E Pitts,
Wella Wang
Robert W Fisher's Documents
Publish Date | Document Type | Title |
---|---|---|
April, 2009 | EIR | Instituto Bioclon S.A. de C.V. - EIR, 2009-06-08 |
June, 2012 | FDA 483 | Emergent BioSolutions Canada Inc - Form 483, 2012-06-21 |
June, 2011 | FDA 483 | Instituto Bioclon S.A. de C.V. - Form 483, 2011-06-22 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more